Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma

BACKGROUND: Large randomised clinical trials and systematic reviews substantiate that tamoxifen is ineffective in improving survival of patients with hepatocellular carcinoma (HCC). However, a recent report suggested that the drug might prolong survival among patients with well preserved liver funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Ciro, De Maio, Ermelinda, Di Maio, Massimo, Signoriello, Giuseppe, Daniele, Bruno, Pignata, Sandro, Annunziata, Annalisa, Perrone, Francesco
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555599/
https://www.ncbi.nlm.nih.gov/pubmed/16863588
http://dx.doi.org/10.1186/1471-2407-6-196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555599/
https://www.ncbi.nlm.nih.gov/pubmed/16863588
http://dx.doi.org/10.1186/1471-2407-6-196

Ejemplares similares